The Future of FA Cancer Research: The Fanconi Anemia Cancer Consortium
FARF Scientific Director, Isis Sroka, talks about the newly developed Fanconi Anemia Cancer Consortium (FACC).
Resource Library
- All Categories
- Transplant
- BRIP1
- Donor
- Financial Support
- Healthcare
- Medicare
- Psychosocial Support
- Stem cells
- Waivers
- Cancer
- Cancer Risk
- Endocrine
- FMLA
- Health Insurance
- Mental Health
- Recursos en español
- Steroids
- Wellbeing
- Finances
- Caregiver Resources
- Endocrinologist
- Food
- Help
- Monitoring
- Research
- Wellness
- Case management
- Endocrinology
- Français
- Hematology
- Newly diagnosed
- Resilience
- Success Rates
- What is FA
- Caregivers
- Chemotherapy
- Esophagus
- Fundraising
- Hematopoietic
- Nutrition
- Resources
- Sun
- Clinical Trials
- Español
- Gastrointestinal
- hereditary
- Oral Cancer
- Science
- Sunscreen
- Acute Myeloid Leukemia
- Comprehensive Care Center
- FA Basics
- Gene
- HLA Matching
- PALB2
- Screening
- Support
- Adults
- Coping
- Family
- HNSCC
- Pathway
- Siblings
- Support group
- Allogeneic
- Counseling
- Family Planning
- Gene Therapy
- Hormones
- Skin
- Symptoms
- Anemia de Fanconi
- Covid-19
- FANC-A
- Genetic
- Infertility
- Peer Support
- Skin Cancer
- Transplant Center
- Anogenital
- FANCJ
- Inheritance
- PGD
- Social Security Disability Insurance
- Transplant Resources
- Bone Marrow
- Dermatology
- FANCN
- Growth
- Insurance
- PGT
- Squamous Cell Carcinoma
- Trauma
- Bone marrow failure
- Diet
- FANCO
- Growth Curve
- IVF
- Post transplant
- SSDI
- Treatment
- BRCA1
- Disability
- FARF
- GvHD
- Lesions
- SSI
- Tumor
- Diagnosis
- BRCA2
- DNA
- Fertility
- Haploidentical
- Maladie de Fanconi
- Private Health Insurance
- Vaccine
- Breast Cancer
- DNA Repair
- Finances & Insurance
- Head and neck
- Medicaid
- Psychological
- Stem Cell Donor
- Vulvar Cancer
